The difficult determinations of causation that arise in tort cases are particularly troublesome to the courts and lawyers when plaintiffs claim that the use of a defendant's product caused their injuries or disease. A perfect illustration of this issue is the concern that hepatitis B vaccine may cause or exacerbate a demyelinating disease in exceptional cases, in particular multiple sclerosis and GuillainBarré syndrome. Indeed, scientific available data does not support such a suggestion, but French judgments specify circumstances under which the causal relationship between these vaccines and these diseases may be proven by presumptions of fact. In these cases, the opportunity to use presumptions for proving such a link does not seem to be justified.
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Introduction
All vaccines and drugs may cause side effects. It is the role of drug safety monitoring and epidemiological studies to identify and monitor these possible side effects, which must further be described in the various information documents that come along with any pharmaceutical product legally marketed in the European Union. Nonetheless, the evidence of an unquestionable causal link between an adverse effect and a substance is made difficult in the presence of scientific uncertainty. A perfect illustration of this issue is the concern that hepatitis B vaccine may cause or exacerbate a demyelinating disease in exceptional cases, in particular multiple sclerosis and Guillain-Barré syndrome 1 . 1 A demyelinating diseases is a nervous system disease. The primary demyelinating disease is multiple sclerosis (MS), "an inflammatory autoimmune disorder of the central nervous system with destruction of the myelin sheath surrounding neurons" (VIAL T, DESCOTES J. Autoimmune diseases and vaccinations. European Journal of Dermatology 2005;14;2:86-90). Guillain-Barré syndrome (GBS) is a type of demyelinating disease of the peripheral nervous system. It is "an acute inflammatory autoimmune demyelinating polyradiculoneuritis that results in progressive paralysis" (ibid). Rheumatoid arthritis is a chronic (long-standing) joint disease that damages the joints of the body. study, the GACVS has decided that the evidence and argument submitted by the researchers were "insufficient to support the hypothesis of a link between hepatitis B vaccination and multiple sclerosis"
and did "not justify discontinuation or modification of immunization programs with HBV" 6 . Given that the benefits of the vaccination have never been questioned, the risk-benefit ratio of the vaccination remains favorable. For this reason, national programmes of hepatitis B vaccination are still recommended by the WHO for all countries.
In spite of the lack of scientific data supporting a causal link between hepatitis B vaccination and the development or the exacerbation of demyelinating diseases, patients who developed such diseases after having received the vaccine claimed since the end of the 1990's that the latter has been the cause of their injury and asked for damages. To determinate whether these patients are entitled to receive compensation, judges have to decide whether the plaintiff has adequately proven that the injury was caused by the vaccine. In these circumstances, the dispute raises the question of the judicial treatment of scientific uncertainty in judgments involving pharmaceutical products. The specific question is: Can judges establish a causal relationship between a product (such a vaccine) and a damage (such a nervous system disease) despite the lack of scientific evidence of the causal link between the two? If so, in what circumstances?
Judges don't often have the opportunity to answer the question of this link. This relationship is indeed generally not disputable. For instance, people with hemophilia should not take aspirin because aspirin increases the risk of bleeding. Nonetheless, cases involving pharmaceutical products and scientific uncertainty usually present courts with a difficult causation issue and plaintiffs can be easily placed in the position of being unable to prove that the product has caused their injury. In the dispute of people who developed serious nervous system diseases shortly after receiving the hepatitis B vaccine, French administrative and judicial courts finally decided to establish in certain circumstances a causal link between vaccination and demyelinating diseases since the end of the 2000's (I). For reasons which will appear evident in the discussion that follows, the decisions of the courts of justice were viewed as a progress for followers of the compensation of "victims" of the vaccination 7 . However, these decisions were criticized in the medical world because it is not biologically plausible that the hepatitis B vaccine can cause or exacerbate demyelination. Besides, such decisions were not unanimously approved in the 
I -The establishment of a causal link between hepatitis B vaccination and demyelinating diseases
In cases related to the hepatitis B vaccination, facts are relatively easy to understand. The plaintiff who has contracted a demyelinating disease after being injected with an hepatitis B vaccine claims that the vaccine caused the disease and asks for compensation. In principle, the claimant has to prove that the damage is attributable to the product and courts must decide whether the claimant has adequately proven that the alleged injury has been caused by the product. In France, judges have answered the question of this causal link between the hepatitis B vaccine and demyelinating diseases in the legal framework of three kinds of liabilities: the liability of the French State for damages resulting from compulsory vaccinations, the employer's liability for damages resulting from work-related accidents, and the product liability The resort to precautionary principle seems not convincing to admit the manufacturer's liability. According to this principle, which applies in the context of scientific uncertainty, "when an activity raises threats of harm to human health or the environment, precautionary measures should be taken even if some cause and effect relationships are not fully established scientifically" (Wingspread Statement on the Precautionary Principle, 1998). Then the question should be: Should the precautionary principle justify precautionary measures, as the prohibition or the restriction of the hepatitis B vaccine, in the presence of the lack of scientific data supporting a causal link between hepatitis B vaccination and the development or the exacerbation of demyelinating diseases? It seems difficult to respond to this question with a positive answer, and thus to admit the manufacturer's liability because he did not take such measures. Indeed, the precautionary principle must apply to the proved benefits, not only to the presumed side effects, and for the moment the risk-benefit ratio of the vaccine remains favorable.
(A) and the cases related to products liability will be explained separately (B). Indeed, French judges apply special texts which take into account the compulsory character of the vaccination for certain employees.
A -The cases related to compulsory vaccinations and work-related accidents
The first judgments rendered in "the hepatitis B vaccination affair" have been delivered by both administrative and judicial courts in relation to compulsory vaccination and work-related accidents. In this legal framework, persons who have contracted demyelinating diseases following after the hepatitis B vaccination have different legal means to claim compensation for their injuries (1). Nevertheless, whatever the legal means chosen by claimants to ask for compensation, judges admit that the causal relationship between the vaccination and their diseases may be presumed under certain conditions (2).
-The law
A system of compensation was established for injury resulting from compulsory vaccination by the Act By instituting the employer's no-fault liability, the Act of 9 April 1898 has allowed victims of work-related accidents to obtain compensation under conditions more advantageous than these offered by tort rules. , the Cour de cassation decided that the incidence of a rheumatoid arthritis which occurred following a vaccination against hepatitis B could be considered, though, as a work-related accident, even though the vaccination was not imposed to the employee. Indeed, the employer asked the employee to be vaccinated. Then, the employee was under the authority of the employer. In the case under consideration, it is important to notice that the court also took into account the evidence of the link between the vaccination and the disease, but the proof of this link was not really relevant. The medical certificate of the employee's general practitioner attested indeed an unquestionable link between the disease and the vaccine, but was in complete contradiction with available scientific data. Moreover, the accident was not sudden.
An important decision rendered on 2 April 2003
22 by the Social Law Chamber of the Cour de cassation admitted that a multiple sclerosis could be considered as a work-related accident. The court delivered a ruling which clearly overturned the whole system of compensation for work-related accidents. In this
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In France, the employer have to take out insurance for its employees covering work-related accidents. The insurance (Caisse de sécurité sociale) covers compensation. new case, judges considered that the disease following a vaccination imposed by employer and carried out for work-related purposes can be considered as an work-related accident, whatever the cause of the disease or the date of the incidence of the disease. In the instant case, judges explicitly admitted that a work-related accident does not have to be sudden for being compensated and implicitly presumed the imputability of the disease to the vaccination . In 2007, the solutions consecrated by the Conseil d'État were remarkable because, at the same time, the Cour de cassation refused to admit such a causal link between the vaccination and similar diseases in cases related to products liability. Indeed, compulsory vaccination and work-related accidents concern only a part of the people who developed demyelinating diseases after hepatitis B vaccination. For persons whose vaccination is not compulsory or when one or several requests have been rejected, the recourse to the common law is possible; it is the products liability.
B -The cases related to products liability
French product liability law can be divided into three main systems: contractual liability, tort liability, and defective product liability. The contractual liability does not concern lawsuits involving hepatitis B vaccine manufacturers because of the French prohibition for pharmaceutical products manufacturers to contract with users of these products 36 . However, in lawsuits involving these manufacturers, the Council Directive 85/374/EEC of 25 July 1985 37 and the tort liability have been applied (1). The most that can be said is that the establishment of the causal link between demyelination and vaccination was controversial (2).
-The law
"The producer shall be liable for damage caused by a defect in his product"
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. The Product Liability
Directive of 1985 introduced a strict liability of manufacturer for damages caused by a defect in the product. The Directive shall apply to pharmaceutical products, ignoring the specificity of these 35 In this case, the fact that the compensation was accorded before by the French State was relevant. The ECJ has called in those circumstances national judges to interpret the national law in accordance with the provisions of EC legislation. See Case 106/89 Marleasing SA v La Comercial Internacional de Alimentacion SA [1990] ECR 1839: the ECJ reiterated that under Article 249 EC, it "lies on all elements of the state, including the courts, and required national courts, when applying national law, whether adopted prior to or after the Directive, to interpret that law in the light of the wording and purpose of the directive". wording and purpose of the directive when the products were put into circulation after this day and before the coming into force of the legislation implementing the Directive.
Applying the intern law to the light of the wording and purpose of the directive, French judges developed a strict liability regime (l'obligation de sécurité de résultat) on the ground of the Articles 1147 (contractual liability) 47 , 1382, 1383 48 (fault liability), and 1384 49 of the French Civil Code (the liability for damages caused by things) 50 . This strict liability regime applies to manufacturers require the same conditions which are consecrated by the Product Liability Directive: the injured person must prove the damage, the defect, and the causal relationship between the damage and the defect but there is no mention of the causal relationship which could normally exists between the use of the product and the damage, neither in the Directive, nor in the strict safety liability regime. Nonetheless, in products liability cases involving hepatitis B vaccine, the question is not to know whether the product defect cause the damage, but to know whether the product itself cause the damage (the imputability of the damage to the product). In all the products liability cases involving hepatitis B vaccine, the main question at which judges must answer is to know whether the alleged damage is imputable to the hepatitis B vaccine.
-Establishing of the law
In the very first products liability cases involving hepatitis B vaccine, judges were not hostile to award compensation to plaintiffs who developed demyelinating diseases after an hepatitis B vaccination and who sued pharmaceutical manufacturers of vaccines 51 . The Court of appeal of Versailles notably 47 The regime were initially consecrated in contractual relationships.
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Pursuant to Article 1382 of the French Civil Code: "any act whatever of man, which causes damage to another, obliges the one by whose fault it occurred, to compensate it." Pursuant to Article 1383 of the French Civil Code: "everyone is liable for the damage he causes not only by his intentional act, but also by his negligent conduct or by his imprudence." Three elements are required to prove the fault liability: a fault, a damage, and a causal link between the two. 49 Pursuant the Article 1384 of the French Civil Code: "a person is liable not only for the damages he causes by his own act, but also for that which is caused by the acts of persons for whom he is responsible, or by things which are in his custody." 50 All studied courts' decisions in the following applied in general these articles (separately or together), interpreting these rules in the light of the wording and purpose of the directive. Exceptionally, courts' decisions mentioned the Article L. 221-1 of the French Consumer Code. Pursuant to article, "products and services must, under normal conditions of use or under other circumstances that may reasonably be foreseen by the professional, offer the safety that can legitimately be expected and must not be a danger to public health." 
A -Critiques of the principle of the establishment
The question of the causal link between a damage and a product is a crucial question in all cases involving health products. However, this is a double-barreled question. The first question is to know whether in a general way a particular damage can be caused by a product (abstract or general causality).
The second question is to know whether a specific damage was caused by a product in a particular case (specific or individual causality). General causality concerns the ability of a product to cause a kind of damage. Specific causality concerns the material link between a product and a damage in a particular case 67 . The general causality is never explicitly requires by texts. Only the specific causality is required.
Indeed, this is not the role of judges to establish a general and abstract link between a product and a damage. In the course of delivering reasons for judgment, judges must pay regard to the background in Nevertheless, judges always implicitly answer the first question of the general causality before answering the question of the specific causality. Generally, this first question is not problematic, but in cases involving health products, especially pharmaceutical products, this question is often problematic because we don't know if the product is able to cause a kind of damage. Then, the question is: Can judges answer the question of a specific link between a product and a damage, in a particular case, while this link is abstractly impossible to prove? In the hepatitis B vaccination affair, judges finally decided to answer the question of the specific causality by using presumptions to establish the specific causal link between a demyelinating disease and a vaccination against hepatitis B. Then, judges did not explicitly answer the question of the general causality but they implicitly recognize this causality. Nevertheless, Furthermore, it seems illogical to research a causal link between the product defect and the damage in the case in which the product cannot cause the damage. The imputability of the damage to the product should be appreciate before the causal link between the eventually product defect and the damage.
Moreover, this imputability should be studied before the product defect. Then, the establishment of such presumption seems not conform the Directive. The same observation should be considered in the context of work-related accidents and compulsory vaccination, even though the link between the accidental consequences of a compulsory vaccination and the vaccination itself is not required by texts.
When this link is established by judges, the proof of this relationship is not persuasive. The link between the alleged injury and the incidence of the vaccination is only based on a coincidental temporal association between the two. In presence of scientific uncertainty related to the causes of the demyelinating diseases, judges should not admit the possibility to prove by presumptions the causal link between such diseases and the vaccination. refused to admit the link between a demyelination and a vaccination against hepatitis B. In consideration of scientific available data and medical expert's opinion, which do not indicate such a link, the court decided that this link could not be deduced from the hypothesis that the risk, not demonstrated, cannot be excluded. The court held that "health products liability requires the prove of the damage, the imputability of the damage to the administration of the product, the product defect, and the causal link between this product defect and the damage". The Cour de cassation reaffirmed that the plaintiff must prove the three classical required elements (the damage, the product defect, and the causal link) but required a new one: the imputability of the damage to the administration of the product. For the first time, this condition was explicitly required, concerning health products liability.
The proof of the imputability of the damage to the use of the product is a constant and obvious condition in all liability products regimes. Even if texts do not mention this condition, the imputability of the damage to the product is usually required by judges. For this reason, the solution consecrated by the court should be approved, especially in the health products liability. The court limited the solution to health products liability. Thus, the Cour de cassation attributed to health products a certain specificity in the legal framework of products liability 76 . The court mentioned the imputability of the damage to the administration of the product and required the proof of this condition concerning health products. It appears evident that the administration of a product only concerns specific products which have to be administrated to the patient or ingested by the organism of the patient. The court probably wanted to remind judges which ruled in the hepatitis B vaccination framework of the necessity to prove both the link between the damage and the product and the link between the damage and the defect product. For this reason, the court's decision should also be approved. Since 2007, such a decision was regrettably never held and courts faced potentially difficult issues concerning the method for establishing the proof of the link between demyelination and vaccination.
B -Critiques of the conditions of the establishment
The reasoning adopted by judges in the hepatitis B vaccination context can be divided in two main parts. Firstly, judges insist on the limits of the scientific truth and thus may consecrate the autonomy of the judicial truth (1). Secondly, judges use presumptions for establishing on a case by case basis a
The decision applied the Articles 1147 and 1384 of the French Civil Code, interpreting these articles in the light of the wording and purpose of the directive.
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See notably BORGHETTI J-S. Thesis. Supra at 65. specific imputability between the product and the damage (2). Nevertheless, the two parts of judges' reasoning are not convincing.
-The non exclusion of the link by science
The vast majority of cases, administrative and judicial judges affirm the limits of the scientific truth and insist on these limits. Indeed, judges usually declare that scientific studies are not able to support a link between demyelinating diseases and hepatitis B vaccination but do not formally exclude such an association. Then, judges demonstrate that scientific available data is unable to answer the question.
Above all, they demonstrate that science cannot formally exclude a causal link between the damage and the product. This element is very important. According to judges, the analysis of the eventual characterization of the link depends on the establishment of this requirement. Scientific non-exclusion of is a prerequisite which is required by the judicially research of such a link. This element shows a certain relationship of Law and Science. If scientific studies formally exclude the relationship of the damage and the product, judges will not be able to characterize the causal relationship. Law and Science become dependent. On the contrary, insofar as the link is not excluded, judges will be able to establish 
-The use of presumptions
Judges consider explicitly or not that they may use presumptions of fact for proving a link between a product and a damage though this link is not proved by scientific available data. By using presumptions, judges adopt an inductive reasoning. Administrative and judicial judges generally considered that three elements are able to constitute serious presumptions of the imputability of the damage to the vaccine: the time proximity between the incidence of the disease and the vaccination, the absence of patient's history, the absence of other causes capable to explain the disease. Although these criteria are far too complicated to be analyzed fully in the present context, it seems worthwhile to pay attention to these elements.
On the other hand, two elements are related to the absence of the other causes of the disease: the absence of patient's history and the absence of other causes which are able to explain the disease. By utilizing these two criteria, judges use a method which consists to eliminate the possible other causes of the damage (causation by exclusion). In this method, it appears that the answer derives from a deductive model (probably) of reasoning. The plaintiff have to prove, first, that he had no history of the disease before the vaccination. Nevertheless, this element seems not relevant because the causes of the disease are largely unknown. We do not identify in particular what could be genetic predispositions for such diseases. However, this solution does not conform the french case law related to the incidence of genetic predispositions in the establishment of causation. Indeed, French courts accept to compensate victims who had genetic predisposition to the damage suffered 77 . The rule which applied is: you take the victim as you find it. Besides, the plaintiff must prove the absence of other causes which are able to explain the disease. This criterion also appears not relevant because the etiology of demyelinating diseases, especially multiple sclerosis, is largely unknown.
On the other hand, judges consecrate a chronological element. This is the element related to the time proximity between the first onset of the disease and the vaccination. In the framework of work-related accidents, the link between the vaccination and the work is implicitly established because of the time proximity between the incidence of the disease and the vaccination even if judges do not mention it. In several decisions, administrative and judicial courts consider explicitly that the first onset of the disease must occur during the few months (often less than two months) following the vaccination hypothesis in which scientific uncertainty is almost non-existent. Finally, the analysis of the decisions rendered in the dispute of the hepatitis B vaccination affair should not lead to the consideration that doubt have to benefit claimants. Indeed, the courts' decisions which condemn a person, whoever it is, to compensate a damage are not justified when no element proves or allows seriously to presume that the damage was caused by a defendant's conduct.
